A significant increase in circulating levels of Gal‐3 (a lectin involved in fibrogenesis through initiation and amplification of the acute inflammatory response by recruiting macrophages to injury sites) was also observed in SSc‐ILD patients (Fig. 3D). The gene discussed is LGALS3; the disease is systemic sclerosis.